Mingyu Li

Dr. Mingyu Li


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JZJinyin Zha
Jinyin Zha
NLNuan Li
Nuan Li
MLMingyu Li
Mingyu Li
XLXinyi Liu
Xinyi Liu
RZRuidi Zhu
Ruidi Zhu
JZJian Zhang
Jian Zhang
Understanding the dynamic conformations of proteins is important for rational drug discovery. While molecular dynamics (MD) simulation is the primary tool for this purpose, it is both resource- and time-consuming. Recent advances in deep learning offer an attractive alternative by generating conformational ensembles directly from protein sequences. However, the scope of applying such models to protein dynamics studies remains underexplored. Here, we tested the performance of a representative model, BioEmu, across several tasks related to protein dynamics. Our results show that BioEmu can not only generate multiple conformations but also effectively reproduce fundamental properties including residue flexibility, motion correlations, and local residue contacts. However, it fails to predict a mutation-induced shift in conformational distribution and exhibits a preference for higher-energy conformations over lower-energy ones in some cases, indicating that it does not reproduce a right Boltzmann-weighted ensemble. Furthermore, the BioEmu-generated conformations provide only limited improvement in ensemble docking. These findings delineate the current capabilities and limitations of sequence-based generative models for conformational sampling. Also, they highlight several directions for future development—that further energy-based fine-tuning is needed for tasks related to conformational distributions and atom-level generative model is required to study the intermolecular relationship.

21 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
XLXun Lu
Xun Lu
XSxinchao Shi
xinchao Shi
JFJigang Fan
Jigang Fan
MLMingyu Li
Mingyu Li
YZYuxiang Zhang
Yuxiang Zhang
ZCZiqiang Chen
Ziqiang Chen
Small-molecule modulators of neurotensin receptor 1 (NTSR1), a class A G-protein-coupled receptor (GPCR), has emerged as promising therapeutic agent for psychiatric disorders and cancer. Interestingly, a chemical group substitution in NTSR1 modulators can launch different types of downstream regulation, highlighting the significance of deciphering the internal fine-tuning mechanism. Here, we conducted a synergistic application of a Gaussian accelerated molecular dynamics simulation, a conventional molecular dynamics simulation, and Markov state models (MSM) to investigate the underlying mechanism of ‘driver chemical groups’ of modulators triggering inverse signaling. The results indicated that the flexibility of the leucine moiety in NTSR1 agonists contributes to the inward displacement of TM7 through a loosely coupled allosteric pathway, while the rigidity of the adamantane moiety in NTSR1 antagonists leads to unfavorable downward transduction of agonistic signaling. Furthermore, we found that R3226.54, Y3196.51, F3537.42, R1483.32, S3567.45, and S3577.46 may play a key role in inducing the activation of NTSR1. Together, our findings not only highlight the ingenious signal transduction within class A GPCRs but also lay a foundation for the development of targeted drugs harboring different regulatory functions of NTSR1.

3 November 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
HZHaiming Zhuang
Haiming Zhuang
DJDong Ji
Dong Ji
JFJigang Fan
Jigang Fan
MLMingyu Li
Mingyu Li
RTRan Tao
Ran Tao
XFXiaohua Fan
Xiaohua Fan
While host miRNA usually plays an antiviral role, the relentless tides of viral evolution have carved out a mechanism to recruit host miRNA as a viral protector. By complementing miR-122 at the 5′ end of the genome, the hepatitis C virus (HCV) gene can form a complex with Argonaute 2 (Ago2) protein to protect the 5′ end of HCV RNA from exonucleolytic attacks. Experiments showed that the disruption of the stem-loop 1(SL1) structure and the 9th nucleotide (T9) of HCV site 1 RNA could enhance the affinity of the Ago2 protein to the HCV site 1 RNA (target RNA). However, the underlying mechanism of how the conformation and dynamics of the Ago2: miRNA: target RNA complex is affected by the SL1 and T9 remains unclear. To address this, we performed large-scale molecular dynamics simulations on the AGO2-miRNA complex binding with the WT target, T9-abasic target and SL1-disruption target, respectively. The results revealed that the T9 and SL1 structures could induce the departing motion of the PAZ, PIWI and N domains, propping up the mouth of the central groove which accommodates the target RNA, causing the instability of the target RNA and disrupting the Ago2 binding. The coordinated motion among the PAZ, PIWI and N domains were also weakened by the T9 and SL1 structures. Moreover, we proposed a new model wherein the Ago2 protein could adopt a more constraint conformation with the proximity and more correlated motions of the PAZ, N and PIWI domains to protect the target RNA from dissociation. These findings reveal the mechanism of the Ago2-miRNA complex’s protective effect on the HCV genome at the atomic level, which will offer guidance for the design of drugs to confront the protection effect and engineering of Ago2 as a gene-regulation tool.

5 June 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
FCFeiying Chen
Feiying Chen
VLVictor Jun Yu Lim
Victor Jun Yu Lim
MLMingyu Li
Mingyu Li
HFHao Fan
Hao Fan
Traditional Chinese Medicine (TCM) has long been regarded as a valuable resource for modern drug discovery. However, the limited availability of recorded entities and information, the complexity and sparsity of the herb–ingredient–target–disease network, and inconsistencies in data representation hinder the effectiveness of high-throughput screening approaches. While some therapeutically valuable compounds from TCM have been discovered through manual experimental screening, such methods are time-consuming and require substantial human resources. To address these challenges, we developed a data-driven and deep learning–based workflow, TCM-Navigator, that enables the in-silico generation, quality control, and physics-based evaluation of TCM-like molecules. The generation is done by TCM-Generator, a transfer learning- and LSTM-based chemical language model that generates standardized, hierarchically structured, and high-throughput–friendly datasets of TCM-like molecules. In this study, we generated a target-nonspecific dataset comprising 3.7 million TCM-like molecules, expanding the number of entities in existing TCM datasets by more than 100-fold. The workflow also enables flexible, goal-driven molecule generation customized for specific targets, yielding three target-specific datasets and multiple high-potential target-ligand pairs. The quality control is done by TCM-Identifier, the first quantitative model specifically designed to capture unique characteristics of TCM, using an AttentiveFP framework with Message Passing Neural Networks (MPNNs). TCM-Identifier is expected to serve as an essential evaluation and guidance tool for TCM-related drug development. Our workflow bridges cutting-edge data science—including deep learning—with biomedical research to tackle longstanding challenges in target identification and molecular design. Its adaptable framework is also transferable to interdisciplinary innovation beyond drug development.

30 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
XLXun Lu
Xun Lu
XSxinchao Shi
xinchao Shi
JFJigang Fan
Jigang Fan
MLMingyu Li
Mingyu Li
YZYuxiang Zhang
Yuxiang Zhang
ZCZiqiang Chen
Ziqiang Chen
Small molecule modulators of neurotensin receptor 1 (NTSR1), a class A G protein-coupled receptor (GPCR), has been emerging as promising therapeutics for psychiatric disorders and cancer. Interestingly, a chemical group substitution of NTSR1 modulators can launch different downstream regulation, highlighting the significance of deciphering the internal fine-tuning mechanism. Here, we conducted synergistic application of Gaussian accelerated molecular dynamics simulation, conventional molecular dynamics simulation, and Markov state models (MSM) to investigate the underpinning mechanism of ‘driver chemical groups’ of modulators triggering inverse signaling. The result indicated that the flexibility of leucine moiety in NTSR1 agonists contributes to the inward displacement of TM7 through a loosely coupled allosteric pathway, while the rigidity of adamantane moiety in NTSR1 antagonists leads to unfavorable downward transduction of agonistic signaling. Furthermore, we found that R3226.54, Y3196.51, F3537.42, R1483.32, S3567.45 and S3577.46 may play a key role in inducing the activation of NTSR1. Together, our findings not only highlight the ingenious signal transduction within class A GPCRs, but also lay a foundation for the development of targeted drugs harboring different regulatory function of NTSR1.